Norway· NO-ID_D40919A3-DFF4-42E0-BB12-69FB4651371F

Adiazine

A sulfadiazine product containing sulfadiazine, registered in Norway by Recordati. The same ATC class is registered in 8 of our 19 countries.

ATC J01EC02

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedAdiazineATCJ01EC02REGISTER NO.NO-ID_D40919A3-DFF4-4…PACKS LISTED2CHECKEDSeptember 25, 2026

Where it is registered

Sulfadiazine is registered in 8 of 19 countries.

Countries holding a registration under ATC J01EC02 (sulfadiazine), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 5 of them publish a price we can compare per daily dose

Sulfadiazine · ATC J01EC02

8 / 19 countries

  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Norwayprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sulfadiazine costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), the median price runs from $0.18 in France to $0.72 in Spain — a ×4.1 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Sulfadiazine · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

  • ES Spain$0.72
  • FR France$0.18
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Sulfadiazine
Manufacturer
Recordati
Country
Norway (NO)
ATC code
J01EC02
ATC class
Sulfadiazine
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 2

  • no_merkevare_id
    ID_D40919A3-DFF4-42E0-BB12-69FB4651371F
  • no_varenummer
    226425
    20

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

97 interactions on record for sulfadiazine.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Sulfadiazine · interactions on record

97 records

  • 5 severe
  • 61 moderate
  • 31 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • Aminobenzoic acidD02BA01severe
  • Aminolevulinic acidL01XD04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sulfadiazine in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sulfadiazine products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Germany · Sulfadiazin Heyl
  • Spain · Sulfadiazina Reig Jofre
  • France · Adiazine
  • United Kingdom (Northern Ireland) · Sulfadiazine Wockhardt Uk
  • Malta · Sulfadiazine Reig Jofre
  • Netherlands · Zilversulfadiazine Sandoz
  • Portugal · Labdiazina

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6d33dc7c-ff5e-4df7-8de2-938b808d21a4
GET /v1/drugs/6d33dc7c-ff5e-4df7-8de2-938b808d21a4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Sulfadiazin",
  "merkevare_id": "ID_D40919A3-DFF4-42E0-BB12-69FB4651371F",
  "name_form_strength": "Adiazine tab 500 mg",
  "prescription_group": "C"
}

See everything about sulfadiazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.